本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

51.80
-0.2200-0.42%
盘后:51.800.00000.00%16:10 EDT
成交量:166.86万
成交额:8,671.28万
市值:48.83亿
市盈率:-108.72
高:52.81
开:51.57
低:51.38
收:52.02
52周最高:68.73
52周最低:22.59
股本:9,426.11万
流通股本:9,276.71万
量比:0.77
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
净资产收益率:-236.35%
总资产收益率:-3.73%
市净率:199.12
市盈率(LYR):-180.90

数据加载中...

2026/09/21

重要事件披露

Form 8-K - Current report
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]